Cell-Free DNA as Disease Biomarkers

In this webinar, Stella Goulopoulou and Iwijn de Vlaminck will discuss how they analyze cell-free DNA to identify biomarkers of various diseases and their complications, including preeclampsia, COVID-19, and transplant rejections.

Event Details:Cell-Free DNA as Disease BiomarkersDate(s):

LIVE Webinar

Tuesday, June 7, 2022
3:00 - 4:30 PM Eastern Time

Register Now

Extracellular DNA in blood has emerged as a minimally invasive biomarker for detecting disease. Apart from sequencing cell-free DNA fragments, researchers can also obtain information about methylation states and expression patterns. Scientists combine these data to understand the pathogenic processes that lead to DNA shedding and to develop biomarkers that can predict diseases before patients develop symptoms. In this webinar brought to you by The Scientist, Stella Goulopoulou and Iwijn de Vlaminck will discuss how they analyze cell-free DNA to identify biomarkers of different diseases and their complications.

Topics to be covered

  • Circulating mitochondrial DNA dynamics in preeclampsia
  • Cell-free biomarkers to predict immune-related complications of COVID-19, organ transplants, and stem cell therapies

Register Now

Meet the Speakers:

Styliani (Stella) Goulopoulou,PhD
Associate Professor of Physiology
Physiology Division
Lawrence D. Longo, MD Center for Perinatal Biology
Loma Linda University, Loma Linda, California

Iwijn De Vlaminck, PhD
Associate Professor
Nancy E. and Peter C. Meinig School of Biomedical
Engineering
Cornell University


Sponsored by

Canopy
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo